ATNF
180 Life Sciences Corp.
2.15
+
0.19
9.69%
0 x 0.00
0 x 0.00
bid
ask
0 @ 04:00 PM
2.11-0.04 (1.86%)
Bearish
14
Bullish
32
sentiment
1.80
day range
2.18
1.33
52 week range
27.93
Prev Close1.96
Open2.03
Low1.80
High2.18
Volume73.97K
Avg. Volume107.27K
Market Cap1.83M
Inst. Own11.20%
Beta0.44
Short Ratio0.16
Div & Yield0.00 /
EPS-52.59
P/E0.00
1yr Target80.00
50day MA2.81
200day MA7.42
CNQ.TO
Canadian Natural Resources Limited
104.32
04:00 PM
-
2.51
2.35%
G.TO
Augusta Gold Corp.
1.02
03:59 PM
+
0.00
0.00%
AAA.AX
BetaShares Australian High Interest Cash ETF
50.27
02:10 AM
+
0.01
0.02%
ACC.NS
ACC Limited
2531.80
06:00 AM
+
6.40
0.25%
600690.SS
Haier Smart Home Co., Ltd.
30.26
03:00 AM
+
1.46
5.07%
0700.HK
Tencent Holdings Limited
347.20
04:08 AM
-
0.40
0.12%
1101.TW
Taiwan Cement Corp.
32.05
01:30 AM
-
0.30
0.93%
20MICRONS.NS
20 Microns Limited
171.75
05:59 AM
-
0.90
0.52%
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session- Benzinga | news.google.com • |
Why Is 180 Life Sciences (ATNF) Stock Up 38% Today? | investorplace.com • |
Penny Stock Investing, 3 High-Growth Industries to Watch | pennystocks.com • |
5 Top Penny Stocks To Watch Today; Time To Buy? | pennystocks.com • |
Using News to Find Penny Stocks to Buy: 3 Tips | pennystocks.com • |
Penny Stocks To Buy This Week? 7 Short Squeeze Stocks To Watch | pennystocks.com • |
Profile
...
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-11-09 | 2023-09 | 0 | -2.85 | N/A | N/A |
2023-08-15 | 2023-06 | 0 | -13.31 | N/A | N/A |
2023-05-15 | 2023-03 | 0 | -24.14 | N/A | N/A |
2022-11-10 | 2022-09 | 0 | -26.62 | N/A | N/A |
2022-08-09 | 2022-06 | 0 | 34.22 | N/A | N/A |
2021-11-15 | 2021-09 | 0 | N/A | N/A | N/A |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-12-08 | DELUCA TERESA | Director | 0.00 | Purchase |
2023-12-27 | FELDMANN MARC | Director | 250.87K | Stock Award(Grant) |
2023-09-03 | GOLD LAWRENCE M | Director | 24.75K | Stock Award(Grant) |
2023-09-03 | MARRONE PAMELA G | Director | 34.86K | Stock Award(Grant) |
2023-09-03 | MCGOVERN DONALD A JR. | Director | 55.29K | Stock Award(Grant) |
2023-05-17 | PAMIR OZAN | Chief Financial Officer | 8.98K | Purchase |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Renaissance Technologies, LLC | 120.00K | 140.39K | 1.21% |
2023-06-29 | Blackrock Inc. | 14.65K | 17.15K | 0.15% |
2023-06-29 | Vanguard Group Inc | 15.38K | 17.99K | 0.15% |
2023-06-29 | Geode Capital Management, LLC | 10.60K | 12.40K | 0.11% |
2023-06-29 | Tower Research Capital LLC (TRC) | 6.78K | 7.93K | 0.07% |
2023-06-29 | Morgan Stanley | 574.00 | 671.00 | 0.01% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 15.38K | 17.99K | 0.15% |
2023-05-30 | Fidelity Extended Market Index Fund | 5.66K | 6.45K | 0.06% |
2023-05-30 | Fidelity Total Market Index Fund | 1.92K | 2.18K | 0.02% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 844.00 | 962.00 | 0.01% |
2023-05-30 | Fidelity Series Total Market Index Fund | 1.42K | 1.62K | 0.01% |
Split
...
Split | Date |
---|---|
1 : 19 | 2024-02-28 |
1 : 20 | 2022-12-19 |
This topic has been deleted. Only users with topic management privileges can see it.
-
Got my 100
-
Got my 100
-
Buying more y’all holding strong
-
$AFNF @JBA The rule of the 3 f’s. If you can fly it float it or fk it rent it.
-
-
-
Weak news. Will end red
-
Is it worth buying Monday?
-
$ATNF dip holding off the squeeze
-
$ATNF still on discount with the market wobble
-
$ATNF here we go
-
$ATNF
-
$ATNF so $ZOM is a pet medical device just awarded international patent to help Cats, Dogs, and more down the road. Currently up 300% at $1 for the year and going to $2 then to $3. By March hopefully $5!! Don’t miss it!!
-
12 Health Care Stocks Moving In Tuesday's Pre-Market Session- Benzinga
news.google.com • -
Why Is 180 Life Sciences (ATNF) Stock Up 38% Today?
investorplace.com • -
Penny Stock Investing, 3 High-Growth Industries to Watch
pennystocks.com • -
5 Top Penny Stocks To Watch Today; Time To Buy?
pennystocks.com • -
Using News to Find Penny Stocks to Buy: 3 Tips
pennystocks.com • -
Penny Stocks To Buy This Week? 7 Short Squeeze Stocks To Watch
pennystocks.com • -
3 Essential Strategies for Penny Stocks Trading in 2023
pennystocks.com • -
The 7 Most Sold-Off Stocks of 2022
investorplace.com • -
Why 180 Life Sciences Shares Are Plunging Today
benzinga.com • -
4 Penny Stocks To Buy For Under $5 Before 2022
pennystocks.com • -
180 Life Sciences Stock Bounces Off Support: What's Next?
benzinga.com • -
180 Life Sciences Corp. Continues To Expand Intellectual Property Portfolio
globenewswire.com • -
180 Life Sciences: Looking At Inflammation With Cannabis (Podcast)
seekingalpha.com • -
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
globenewswire.com • -
180 Life Sciences Corp. Announces Closing of $15.0 Million Private Placement
globenewswire.com • -
Why 180 Life Sciences Stock Is Falling Today
fool.com • -
180 Life Sciences Corp. Announces $15.0 Million Private Placement
globenewswire.com • -
180 Life Sciences Announces Selection of Lead Synthetic CBD Analogue
globenewswire.com • -
180 Life Sciences Joins Russell Microcap® Index
globenewswire.com • -
7 Reddit Penny Stocks to Buy for a Biotech Boom
investorplace.com • -
ATNF Stock: Over 30% Increase Intraday Explanation
pulse2.com • -
What's Happening With ATNF Stock And CELC Stock?
benzinga.com • -
5 Reddit Penny Stocks Seeing the Most Chatter Friday
investorplace.com • -
DISCB and 6 Other Reddit Stocks Waiting for a Short Squeeze
investorplace.com • -
180 Life Science Rallies 18%: Technical Levels To Watch
benzinga.com • -
ATNF Stock: Why 180 Life Sciences Is Soaring Higher Today
investorplace.com • -
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
globenewswire.com • -
7 Reddit Penny Stocks Seeing the Most Chatter Today
investorplace.com •